Recombinant Human lcrV Protein，His

The LcrV protein, a key virulence factor of the pathogenic bacterium Yersinia pestis, plays a critical role in the bacteria's ability to evade the host immune system. As a lipoprotein, LcrV is essential for the assembly and function of the type III secretion system (T3SS), which enables Y. pestis to deliver effector proteins directly into host cells, thereby facilitating infection and immune evasion. Research has increasingly focused on the potential of LcrV as a vaccine candidate due to its immunogenic properties, which can elicit strong immune responses in vaccinated hosts. Additionally, studies have shown that LcrV is conserved among various Yersinia species, heightening its significance not only for understanding Y. pestis pathogenesis but also for devising broad-spectrum vaccines against Yersinia infections. Recombinant LcrV protein has been produced in various expression systems, allowing for detailed structural and functional analyses. These investigations aim to elucidate the protein's mechanisms of action and its interactions with host immune components. By exploring the immunological responses triggered by LcrV, researchers are uncovering the protein's potential as a crucial target for therapeutic interventions and vaccine development against plague and related Yersinia diseases. Given the historical impact of Y. pestis as a causative agent of plague pandemics, ongoing research into the LcrV protein not only contributes to our understanding of bacterial pathogenesis but also has significant public health implications in terms of prevention and control strategies against this deadly pathogen.